
Our Story: Establishing Drug Development Consultancy
In the late 2000s, biotech innovation was booming—yet too many promising drugs never reached the market. Not because of the science, but because of execution: the wrong trials, the wrong strategies, the wrong designs.
Alejandra Mørk had seen this pattern again and again as a senior pharma executive.
“What was missing was someone who could see the full horizon.” In 2008, she acquired KLIFO—not to take it over, but to reinvent it. The vision was clear: build a consulting house for pharmaceutical development, led by senior experts who could bridge strategy and execution.
“We’re not an army of junior consultants here to fill hours. We’re the people who step in when it really matters.”

Our Story: Building Clinical Trial Supply
In clinical development, access to even the most promising therapy can fail if the clinical supply chain is not right. Not because of science, but because patients don’t get the right medicine, at the right time, in the right place and in the right condition.
That’s why KLIFO built its Clinical Trial Supply unit in 2008, spearheaded by Christina Vinum.
From the beginning, the vision was clear: bring together experts who understand every step of the supply chain—from packaging design and labelling, to distribution strategies and global logistics. The goal wasn’t just to move boxes, but to ensure that every supply chain decision supports the success of the trial itself.
“Supplying a clinical trial is not about packaging and shipments—it’s about enabling patients to participate safely, reliably, and on time.”


The KLIFO promise
Good medicines deserve to reach the market — but success requires more than science. It takes experience, regulatory maturity and flawless execution.
When you work with KLIFO, you get senior professionals who take ownership. We embed into your team, apply vertical insight, and ensure your drug product is developed, documented and delivered right.
Ready to address your clinical development needs?

